DGAP-News: MediClin AG / Key word(s): Interim Report
MediClin AG: Group sales in the first nine months of 2011 increased by
1.3 percent - Group result below previous year's figure due to higher
expenses and investments and restrained development in the post-acute
segement
10.11.2011 / 08:57
---------------------------------------------------------------------
Offenburg, November 10, 2011 - MEDICLIN Aktiengesellschaft (MediClin) has
achieved Group sales of EUR 367.7 mill. (9 M 2010: EUR 363.0 mill.) in the
first nine months of 2011, thus being EUR 4.7 mill. or 1.3% more than in
the comparable previous year's period. The Group's operating result of this
period of EUR 7.0 mill. was EUR 5.1 mill. below the previous year's value.
Across all segments this decrease in operating result was caused by
expenses that increased more than sales and occupancy rates in the
post-acute segment, which were lower in comparison to the high level of the
same period last year.
In the reporting period capital expenditure was EUR 24.0 mill. (9 M 2011:
EUR 17.5 mill.). Cash and cash equivalents per September 30, 2011 amounted
close to EUR 47.0 mill., equity ratio was 48.0%.
The result attributable to the shareholders of MEDICLIN Aktiengesellschaft
amounted to EUR 0.6 mill. (9 M 2010: EUR 6.2 mill.).
Development of the segments
Sales in the post-acute segment increased by EUR 1.1 mill. or 0.6% up to
EUR 207.1 mill. (9 M 2010: EUR 206.0 mill.) compared to the previous year's
value. Segment result was EUR 0.2 mill. (9 M 2010: EUR 5.2 mill.). Against
last year the slight increase in sales could not compensate the higher
expenses including depreciation of about EUR 7.7 mill.
Sales in the acute segment increased by EUR 2.6 mill. or 1.8 % up to EUR
150.7 mill. (9 M 2010: EUR 148.1 mill.) in the nine-month comparison. The
segment result of EUR 12.6 mill. (9 M 2010: EUR 12.7 mill.) was on par with
last year, despite higher expenditures.
The nursing care business area continued to develop positively. Here, sales
rose from EUR 8.3 mill. to EUR 8.8 mill. During the reporting period,
occupancy rates were calculated at 94.8 % and were thus 3.6 percentage
points above the previous year's value.
Outlook
Thus far in 2011 lower indication-based benchmarks on the average length of
patient stay in the rehabilitation sector enacted at the end of 2010 by the
German statutory pension insurance scheme, as well as a lower number of
patients, have had a diminishing effect on the number of nursing days in
post-acute segment. Particularly the demand for services
assigned to curative treatment is in decline. In nearly all medical
indications, the demand on the part of the social security pension funds
for services involving subsequent nursing treatments was almost at the same
level as last year. In the post-acute segment, these constitute more than
60 % of the provided medical services - calculated on the basis of nursing
days.
As the noticeable chance in the occupancy behaviour of the social security
pension funds, observed during the first half of 2011, has continued into
the second half of 2011, the operating result for the 2011 financial year
will be affected, despite countermeasures taken. At present, an operating
result in the upper single-digit range is expected.
The interim report as of September 30, 2011 is available under
www.mediclin.de in German and English.
About MediClin AG (Ticker: MED; WKN: 659 510)
MediClin AG is a nation-wide clinic operator and large provider of services
in the area of Psycho- and Neurosciences as well as Orthopaedic. With 34
clinics and 7 nursing care facilities and 11 Medizinische
Versorgungszentren (medical care units) in 11 federal states MediClin has a
total capacity of approximately 8,000 beds. MediClins' facilities include
acute care clinics, i.e., general hospitals, special treatment facilities,
specialised hospitals and clinics for post-acute treatment and medical
rehabilitation. MediClin has approximately 8,300 employees..
End of Corporate News
---------------------------------------------------------------------
10.11.2011 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: MediClin AG
OkenstraÃe 27
77652 Offenburg
Germany
Phone: +49 (0)781 488-189
Fax: +49 (0)781 488-184
E-mail: alexandra.muehr@mediclin.de
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
145619 10.11.2011
DGAP-News: MediClin AG: Group sales in the first nine months of 2011 increased by 1.3 percent - Group result below previous year's figure due to higher expenses and investments and restrained development in the post-acute segement
| Source: EQS Group AG